EUVIMEDEUVIMED entdecken
Crossref

Carrier-free spherical nucleic acids engineered by coordination-competition for programmable release and cancer immunotherapy

Wanrui Shi, Shihao Wang, Li Rong, Yang Yang, Wenjie Feng, Yanbo Wang, Yi Liu, Hao Zhang

Acta Biomaterialia · 2026-06 · 216 · 333-347

DOI: 10.1016/j.actbio.2026.04.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-06. Verfasst von Wanrui Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, The First Hospital of Jilin University, Changchun 130021, PR China; State Key Laboratory of Supramo…. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms, Nucleic Acids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oligonucleotide-based therapeutics offer precise genetic and immunological modulation but meet critical barriers including instability, poor cellular uptake, and carrier-associated toxicity. Although spherical nucleic acids (SNAs) provide a robust framework, the conventional designs relied on inactive cores impede multifunctional combinations and raise safety concerns. Here, we propose a coordination-competition strategy to construct carrier-free SNAs by templating metal-phenolic networks (MPNs) with therapeutic oligonucleotides. The as-constructed SNAs possess active drug cores and dense nucleic acid shells, enabling programmable release, efficient lysosomal escape, and robust functionalization with aptamers, small interfering RNAs (siRNAs), and cytosine guanine dinucleotide (CpG) oligodeoxynucleotide (ODN) adjuvants. These multifunctional SNAs combine chemotherapy, gene therapy, and immunotherapy within a single nanoplatform, achieving potent tumor inhibition, immune reprogramming, and durable protection in nanovaccine models. This work establishes a universal and translational framework for designing next-generation nucleic acid nanoformulations focused on but not limited to oncotherapy. STATEMENT OF SIGNIFICANCE: Oligonucleotide-based therapeutics are promising but remain limited by poor stability, inefficient delivery, and safety concerns associated with inert nanocarriers. This work introduces a coordination-competition strategy to construct carrier-free spherical nucleic acids (SNAs) using metal-phenolic networks as active, functional cores. Unlike conventional SNAs, this design eliminates inert materials while enabling high-density nucleic acid loading and modular therapeutic integration. Importantly, distinct coordination chemistries allow programmable release of drugs and oligonucleotides in tumors and immune organs. This general and versatile platform expands the chemical scope of SNAs and offers a new paradigm for designing safer, multifunctional nanomedicines for cancer immunotherapy and beyond.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyNeoplasmsNucleic AcidsAnimalsHumansRNA, Small InterferingOligodeoxyribonucleotidesMiceCell Line, TumorAptamers, Nucleotide

Stichwörter der Autor:innen

Coordination-competitionMetal-phenolic networksOligonucleotidesProgrammable releaseSpherical nucleic acids

Substanzen

RNA, Small InterferingNucleic AcidsOligodeoxyribonucleotidesAptamers, Nucleotide

Autor:innen und Institutionen

  • Department of Plastic and Reconstructive Surgery, The First Hospital of Jilin University, Changchun 130021, PR China; State Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin Universit…
  • State Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun 130012, PR China.
  • Department of Plastic and Reconstructive Surgery, The First Hospital of Jilin University, Changchun 130021, PR China.
  • Department of Plastic and Reconstructive Surgery, The First Hospital of Jilin University, Changchun 130021, PR China; Joint Laboratory of Opto-Functional Theranostics in Medicine and Chemistry, Institute of Translationa…
  • Department of Urology, The First Hospital of Jilin University, Changchun 130021, PR China. Electronic address: wangyanb@jlu.edu.cn.

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • National Natural Science Foundation of China

Zitieren

APA

Shi, W., Wang, S., Rong, L., Yang, Y., Feng, W., Wang, Y., Liu, Y., & Zhang, H. (2026). Carrier-free spherical nucleic acids engineered by coordination-competition for programmable release and cancer immunotherapy. Acta Biomaterialia, 216, 333-347. https://doi.org/10.1016/j.actbio.2026.04.008

Vancouver

Shi W, Wang S, Rong L, Yang Y, Feng W, Wang Y, et al. Carrier-free spherical nucleic acids engineered by coordination-competition for programmable release and cancer immunotherapy. Acta Biomaterialia. 2026;216:333-347. doi:10.1016/j.actbio.2026.04.008

BibTeX
@article{Shi2026,
  author = {Shi, Wanrui and Wang, Shihao and Rong, Li and Yang, Yang and Feng, Wenjie and Wang, Yanbo and Liu, Yi and Zhang, Hao},
  title = {Carrier-free spherical nucleic acids engineered by coordination-competition for programmable release and cancer immunotherapy},
  journal = {Acta Biomaterialia},
  year = {2026},
  volume = {216},
  pages = {333--347},
  doi = {10.1016/j.actbio.2026.04.008}
}
Kostenlos starten →